Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials
- PMID: 27189356
- PMCID: PMC4957258
- DOI: 10.1200/JOP.2015.008946
Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials
Abstract
Purpose: Less than 10% of patients enrolled in clinical trials are minorities. The patient navigation model has been used to improve access to medical care but has not been evaluated as a tool to increase the participation of minorities in clinical trials. The Increasing Minority Participation in Clinical Trials project used patient navigators (PNs) to enhance the recruitment of African Americans for and their retention in therapeutic cancer clinical trials in a National Cancer Institute-designated comprehensive cancer center.
Methods: Lay individuals were hired and trained to serve as PNs for clinical trials. African American patients potentially eligible for clinical trials were identified through chart review or referrals by clinic nurses, physicians, and social workers. PNs provided two levels of services: education about clinical trials and tailored support for patients who enrolled in clinical trials.
Results: Between 2007 and 2014, 424 African American patients with cancer were referred to the Increasing Minority Participation in Clinical Trials project. Of those eligible for a clinical trial (N = 378), 304 (80.4%) enrolled in a trial and 272 (72%) consented to receive patient navigation support. Of those receiving patient navigation support, 74.5% completed the trial, compared with 37.5% of those not receiving patient navigation support. The difference in retention rates between the two groups was statistically significant (P < .001). Participation of African Americans in therapeutic cancer clinical trials increased from 9% to 16%.
Conclusion: Patient navigation for clinical trials successfully retained African Americans in therapeutic trials compared with non-patient navigation trial participation. The model holds promise as a strategy to reduce disparities in cancer clinical trial participation. Future studies should evaluate it with racial/ethnic minorities across cancer centers.
Copyright © 2016 by American Society of Clinical Oncology.
Figures
Comment in
-
Towards cancer equity via patient outreach.Nat Rev Cancer. 2021 Nov;21(11):684-685. doi: 10.1038/s41568-021-00404-7. Nat Rev Cancer. 2021. PMID: 34522023 No abstract available.
References
-
- Corbie-Smith G, Miller WC, Ransohoff DF. Interpretations of ‘appropriate’ minority inclusion in clinical research. Am J Med. 2004;116:249–252. - PubMed
-
- Alexander-Bridges M, Doan LL. Commentary on “increasing minority participation in clinical research”: a white paper from the endocrine society. J Clin Endocrinol Metab. 2007;92:4557–4559. - PubMed
-
- Institute of Medicine Committee on Cancer Clinical Trials NCGP: A national cancer clinical trials system for the 21st century: Reinvigorating the NCI Cooperative Group Program. Washington, DC, National Academies Press, 2010. - PubMed
-
- Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA. 2004;291:2720–2726. - PubMed
-
- Stewart JH, Bertoni AG, Staten JL, et al. Participation in surgical oncology clinical trials: Gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007;14:3328–3334. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials